Showing results (41-50 of 77) with videos related to
Sort By:
Pageof 8
Journal of Clinical Nursing|July 27, 2012
A randomised trial of nursing interventions supporting recovery of the postmastectomy patientHo Soon Michelle Cho, Gail C Davis, Jae Eun Paek, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011John A Olson, Linda M McCall, Peter Beitsch, et al.JAMA|February 10, 2011
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trialArmando E Giuliano, Kelly K Hunt, Karla V Ballman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2007
Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011Anthony Lucci, Linda Mackie McCall, Peter D Beitsch, et al.Annals of Plastic Surgery|June 2, 2011
Aesthetic subunit of the breast: an analysis of women's preference and clinical implicationsSteven H Bailey, Michel Saint-Cyr, Georgette Oni, et al.Annals of Surgery|September 10, 2014
Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical TrialJudy C Boughey, Linda M McCall, Karla V Ballman, et al.Annals of Surgical Oncology|March 24, 2010
Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010Lee G Wilke, Karla V Ballman, Linda M McCall, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 6, 2019
Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trialAsal Rahimi, Osama Mohamad, Kevin Albuquerque, et al.The Lancet. Oncology|November 19, 2013
Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trialAman U Buzdar, Vera J Suman, Funda Meric-Bernstam, et al.Breast Cancer Research and Treatment|March 30, 2023
Aspirin use is associated with improvement in distant metastases outcome in patients with residual disease after neoadjuvant chemotherapyChristopher Johns, Steven K Montalvo, M'Kay Cauble, et al.Pageof 8